Dennis Roop
Concepts (838)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epidermis | 84 | 2024 | 157 | 8.730 |
Why?
| | Keratins | 113 | 2016 | 173 | 6.820 |
Why?
| | Keratinocytes | 56 | 2024 | 252 | 4.270 |
Why?
| | Skin Neoplasms | 57 | 2024 | 849 | 3.960 |
Why?
| | Membrane Proteins | 39 | 2022 | 1154 | 3.670 |
Why?
| | Skin | 53 | 2024 | 765 | 3.250 |
Why?
| | Trans-Activators | 26 | 2013 | 388 | 2.890 |
Why?
| | Papilloma | 31 | 2011 | 52 | 2.080 |
Why?
| | Phosphoproteins | 17 | 2013 | 338 | 2.080 |
Why?
| | Cell Transformation, Neoplastic | 25 | 2016 | 333 | 2.070 |
Why?
| | Cell Differentiation | 74 | 2024 | 2003 | 2.040 |
Why?
| | Hyperkeratosis, Epidermolytic | 17 | 2008 | 21 | 1.990 |
Why?
| | Mice, Transgenic | 66 | 2017 | 2180 | 1.930 |
Why?
| | NF-E2-Related Factor 2 | 7 | 2022 | 94 | 1.900 |
Why?
| | Stem Cells | 19 | 2017 | 602 | 1.870 |
Why?
| | Mice | 189 | 2024 | 18048 | 1.750 |
Why?
| | Genes, ras | 25 | 2012 | 95 | 1.540 |
Why?
| | Animals | 232 | 2024 | 37657 | 1.470 |
Why?
| | Hair Follicle | 14 | 2020 | 48 | 1.400 |
Why?
| | Genetic Therapy | 12 | 2014 | 315 | 1.240 |
Why?
| | Vitiligo | 8 | 2024 | 42 | 1.240 |
Why?
| | Mutation | 37 | 2024 | 4013 | 1.120 |
Why?
| | Melanocytes | 8 | 2024 | 66 | 1.110 |
Why?
| | Point Mutation | 13 | 2009 | 237 | 1.100 |
Why?
| | Skin Diseases | 8 | 2014 | 147 | 1.050 |
Why?
| | Induced Pluripotent Stem Cells | 6 | 2024 | 265 | 1.020 |
Why?
| | Carcinoma, Squamous Cell | 20 | 2016 | 642 | 1.020 |
Why?
| | Transforming Growth Factor alpha | 10 | 2000 | 57 | 0.930 |
Why?
| | Collagen Type VII | 2 | 2024 | 28 | 0.920 |
Why?
| | Cell Division | 20 | 2016 | 798 | 0.920 |
Why?
| | Ichthyosis | 7 | 2016 | 13 | 0.910 |
Why?
| | Mice, Knockout | 35 | 2018 | 3068 | 0.910 |
Why?
| | Epidermolysis Bullosa Dystrophica | 2 | 2024 | 42 | 0.900 |
Why?
| | Disease Models, Animal | 31 | 2020 | 4404 | 0.900 |
Why?
| | Gene Expression Regulation | 31 | 2016 | 2599 | 0.860 |
Why?
| | Phenotype | 28 | 2021 | 3166 | 0.850 |
Why?
| | Ectodermal Dysplasia | 5 | 2009 | 18 | 0.850 |
Why?
| | Cornified Envelope Proline-Rich Proteins | 7 | 2018 | 9 | 0.830 |
Why?
| | Morphogenesis | 7 | 2010 | 171 | 0.830 |
Why?
| | Base Sequence | 49 | 2016 | 2180 | 0.820 |
Why?
| | Melanoma | 10 | 2020 | 772 | 0.820 |
Why?
| | Gene Expression Regulation, Developmental | 14 | 2015 | 874 | 0.810 |
Why?
| | DNA-Binding Proteins | 15 | 2015 | 1478 | 0.810 |
Why?
| | Ultraviolet Rays | 9 | 2024 | 401 | 0.800 |
Why?
| | Genes, fos | 10 | 2000 | 37 | 0.790 |
Why?
| | Neoplasms, Experimental | 4 | 2019 | 174 | 0.780 |
Why?
| | Genes, p53 | 10 | 2012 | 68 | 0.770 |
Why?
| | Transgenes | 13 | 2016 | 186 | 0.770 |
Why?
| | Tetradecanoylphorbol Acetate | 21 | 2010 | 156 | 0.760 |
Why?
| | Tumor Suppressor Proteins | 8 | 2009 | 325 | 0.740 |
Why?
| | Proto-Oncogene Proteins c-myc | 6 | 2010 | 162 | 0.730 |
Why?
| | Tumor Suppressor Protein p53 | 6 | 2011 | 528 | 0.720 |
Why?
| | Skin Pigmentation | 4 | 2024 | 48 | 0.720 |
Why?
| | Cells, Cultured | 39 | 2024 | 4208 | 0.710 |
Why?
| | Intermediate Filament Proteins | 22 | 2012 | 58 | 0.710 |
Why?
| | Jews | 1 | 2021 | 24 | 0.710 |
Why?
| | Gene Expression Regulation, Neoplastic | 18 | 2015 | 1431 | 0.710 |
Why?
| | Skin Physiological Phenomena | 7 | 2008 | 25 | 0.700 |
Why?
| | Neoplastic Stem Cells | 7 | 2016 | 400 | 0.650 |
Why?
| | Cell Lineage | 5 | 2010 | 350 | 0.640 |
Why?
| | Ichthyosis, Lamellar | 2 | 2016 | 9 | 0.620 |
Why?
| | Cytoskeletal Proteins | 9 | 2012 | 156 | 0.620 |
Why?
| | Intravital Microscopy | 1 | 2019 | 24 | 0.620 |
Why?
| | Transcription Factors | 16 | 2015 | 1703 | 0.610 |
Why?
| | Molecular Sequence Data | 34 | 2012 | 2929 | 0.600 |
Why?
| | Genes, myc | 4 | 2011 | 48 | 0.600 |
Why?
| | Signal Transduction | 22 | 2020 | 5144 | 0.560 |
Why?
| | Pluripotent Stem Cells | 2 | 2010 | 80 | 0.560 |
Why?
| | Hair | 6 | 2012 | 88 | 0.560 |
Why?
| | Hedgehog Proteins | 7 | 2017 | 200 | 0.550 |
Why?
| | Genes | 15 | 2008 | 229 | 0.550 |
Why?
| | Immunity, Cellular | 1 | 2019 | 269 | 0.540 |
Why?
| | Skin Diseases, Genetic | 6 | 2020 | 13 | 0.540 |
Why?
| | Keratin-6 | 5 | 2016 | 6 | 0.520 |
Why?
| | Mice, Mutant Strains | 14 | 2016 | 309 | 0.520 |
Why?
| | Promoter Regions, Genetic | 17 | 2016 | 1242 | 0.500 |
Why?
| | Multipotent Stem Cells | 3 | 2010 | 20 | 0.490 |
Why?
| | Protein Isoforms | 8 | 2008 | 398 | 0.490 |
Why?
| | Amino Acid Sequence | 30 | 2012 | 2158 | 0.490 |
Why?
| | Head and Neck Neoplasms | 5 | 2016 | 553 | 0.480 |
Why?
| | Humans | 132 | 2024 | 141187 | 0.480 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2016 | 120 | 0.480 |
Why?
| | Ultraviolet Therapy | 4 | 2024 | 17 | 0.470 |
Why?
| | Keratoderma, Palmoplantar | 3 | 2014 | 6 | 0.470 |
Why?
| | Cell Proliferation | 14 | 2024 | 2504 | 0.460 |
Why?
| | Pachyonychia Congenita | 3 | 2014 | 4 | 0.460 |
Why?
| | Transforming Growth Factor beta | 8 | 2009 | 497 | 0.460 |
Why?
| | Viral Proteins | 4 | 2002 | 369 | 0.450 |
Why?
| | Genetic Vectors | 7 | 2013 | 336 | 0.440 |
Why?
| | Tretinoin | 11 | 2014 | 122 | 0.440 |
Why?
| | Gene Deletion | 8 | 2012 | 388 | 0.430 |
Why?
| | Keratosis | 7 | 2000 | 16 | 0.430 |
Why?
| | Epithelium | 14 | 2004 | 316 | 0.430 |
Why?
| | Animals, Newborn | 23 | 2007 | 863 | 0.430 |
Why?
| | Cell Culture Techniques | 3 | 2014 | 368 | 0.420 |
Why?
| | DNA | 24 | 2018 | 1444 | 0.420 |
Why?
| | Cadherins | 3 | 2016 | 202 | 0.420 |
Why?
| | Cell Cycle | 3 | 2012 | 597 | 0.420 |
Why?
| | Mice, Inbred ICR | 10 | 2011 | 119 | 0.410 |
Why?
| | Genes, Dominant | 6 | 2016 | 97 | 0.410 |
Why?
| | Amniotic Fluid | 2 | 2012 | 79 | 0.410 |
Why?
| | Mosaicism | 5 | 2014 | 74 | 0.400 |
Why?
| | Nails, Malformed | 2 | 2005 | 7 | 0.390 |
Why?
| | Carcinoma, Basal Cell | 2 | 2017 | 71 | 0.390 |
Why?
| | Up-Regulation | 8 | 2020 | 859 | 0.390 |
Why?
| | Abnormalities, Multiple | 3 | 2014 | 197 | 0.380 |
Why?
| | Proteomics | 2 | 2016 | 1134 | 0.380 |
Why?
| | Keratin-10 | 8 | 2016 | 8 | 0.380 |
Why?
| | 9,10-Dimethyl-1,2-benzanthracene | 17 | 2010 | 24 | 0.380 |
Why?
| | Eyelids | 2 | 2009 | 43 | 0.380 |
Why?
| | Wnt Signaling Pathway | 2 | 2024 | 202 | 0.380 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2012 | 36 | 0.380 |
Why?
| | Melanoma, Experimental | 3 | 1998 | 111 | 0.370 |
Why?
| | DNA Primers | 13 | 2010 | 510 | 0.370 |
Why?
| | Cleft Lip | 2 | 2009 | 59 | 0.370 |
Why?
| | Transcription, Genetic | 23 | 2017 | 1487 | 0.370 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2012 | 429 | 0.370 |
Why?
| | Cleft Palate | 2 | 2009 | 75 | 0.360 |
Why?
| | Carcinogens | 12 | 2010 | 127 | 0.360 |
Why?
| | Oncogene Proteins v-fos | 6 | 1999 | 11 | 0.360 |
Why?
| | Mutation, Missense | 3 | 2016 | 339 | 0.360 |
Why?
| | Gene Transfer Techniques | 4 | 2002 | 176 | 0.360 |
Why?
| | Wound Healing | 6 | 2010 | 348 | 0.350 |
Why?
| | Apoptosis | 9 | 2012 | 2574 | 0.350 |
Why?
| | Calcium | 12 | 2010 | 1187 | 0.340 |
Why?
| | Centrosome | 4 | 2012 | 71 | 0.340 |
Why?
| | Hyperplasia | 12 | 2002 | 176 | 0.340 |
Why?
| | Proteins | 3 | 2016 | 1010 | 0.340 |
Why?
| | Pedigree | 11 | 2000 | 511 | 0.330 |
Why?
| | RNA, Messenger | 35 | 2016 | 2828 | 0.330 |
Why?
| | Integrases | 5 | 2004 | 121 | 0.320 |
Why?
| | Alleles | 7 | 2016 | 891 | 0.320 |
Why?
| | Gene Targeting | 5 | 2008 | 83 | 0.320 |
Why?
| | Stem Cell Niche | 1 | 2010 | 58 | 0.310 |
Why?
| | Epidermolysis Bullosa Simplex | 4 | 2004 | 10 | 0.310 |
Why?
| | Transcription Factor AP-2 | 2 | 2008 | 82 | 0.300 |
Why?
| | Immunotherapy | 3 | 2020 | 640 | 0.300 |
Why?
| | Genes, Recessive | 2 | 2021 | 78 | 0.300 |
Why?
| | Mice, Nude | 12 | 2016 | 691 | 0.300 |
Why?
| | Female | 74 | 2024 | 75515 | 0.290 |
Why?
| | Polymerase Chain Reaction | 13 | 2002 | 1056 | 0.280 |
Why?
| | Mice, Inbred Strains | 13 | 2010 | 412 | 0.280 |
Why?
| | Keratins, Type II | 1 | 2007 | 2 | 0.280 |
Why?
| | Adenoviridae | 3 | 1998 | 201 | 0.270 |
Why?
| | Fluorescent Antibody Technique | 19 | 2004 | 386 | 0.270 |
Why?
| | Aurora Kinases | 3 | 2012 | 28 | 0.270 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2007 | 18 | 0.260 |
Why?
| | Lipid Metabolism | 5 | 2018 | 528 | 0.260 |
Why?
| | Aurora Kinase A | 3 | 2012 | 55 | 0.260 |
Why?
| | Disease Progression | 6 | 2019 | 2793 | 0.260 |
Why?
| | Keratin-14 | 6 | 2012 | 15 | 0.260 |
Why?
| | Transcription Factor AP-1 | 3 | 2014 | 88 | 0.260 |
Why?
| | Mifepristone | 9 | 2009 | 63 | 0.250 |
Why?
| | Mice, Inbred BALB C | 17 | 2020 | 1274 | 0.250 |
Why?
| | Skin Transplantation | 6 | 2024 | 85 | 0.250 |
Why?
| | Amino Acid Substitution | 4 | 2000 | 310 | 0.250 |
Why?
| | Proto-Oncogenes | 1 | 2006 | 28 | 0.250 |
Why?
| | Ichthyosiform Erythroderma, Congenital | 2 | 2018 | 6 | 0.250 |
Why?
| | Genes, Reporter | 4 | 2009 | 274 | 0.240 |
Why?
| | Models, Biological | 8 | 2016 | 1828 | 0.240 |
Why?
| | Homeostasis | 3 | 2020 | 636 | 0.240 |
Why?
| | Kelch-Like ECH-Associated Protein 1 | 3 | 2016 | 11 | 0.240 |
Why?
| | Cell Line | 14 | 2018 | 2885 | 0.240 |
Why?
| | Genomic Instability | 4 | 2011 | 57 | 0.230 |
Why?
| | Male | 50 | 2024 | 69783 | 0.230 |
Why?
| | Oncogene Protein p21(ras) | 4 | 2004 | 16 | 0.230 |
Why?
| | Gene Expression | 12 | 2015 | 1491 | 0.230 |
Why?
| | Mice, Inbred C57BL | 19 | 2015 | 5887 | 0.230 |
Why?
| | Intermediate Filaments | 6 | 2015 | 26 | 0.230 |
Why?
| | Mouth Neoplasms | 2 | 2004 | 89 | 0.230 |
Why?
| | Keratin-1 | 2 | 2016 | 2 | 0.220 |
Why?
| | Skin Diseases, Vesiculobullous | 2 | 1999 | 18 | 0.220 |
Why?
| | Phosphodiesterase 4 Inhibitors | 1 | 2024 | 5 | 0.220 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 5 | 2015 | 263 | 0.220 |
Why?
| | Lipids | 4 | 2018 | 689 | 0.220 |
Why?
| | Prenatal Diagnosis | 2 | 1998 | 190 | 0.220 |
Why?
| | ras Proteins | 4 | 2013 | 148 | 0.220 |
Why?
| | Protein Precursors | 9 | 2006 | 133 | 0.220 |
Why?
| | Retinoids | 2 | 1997 | 34 | 0.210 |
Why?
| | beta Catenin | 3 | 2020 | 258 | 0.210 |
Why?
| | Heterozygote | 4 | 2010 | 307 | 0.210 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2024 | 86 | 0.210 |
Why?
| | Cocarcinogenesis | 4 | 2000 | 13 | 0.200 |
Why?
| | Sequence Analysis, DNA | 6 | 2016 | 824 | 0.200 |
Why?
| | Lac Operon | 2 | 2000 | 44 | 0.200 |
Why?
| | Proto-Oncogene Proteins | 5 | 2013 | 623 | 0.200 |
Why?
| | Transfection | 10 | 2017 | 943 | 0.200 |
Why?
| | Transduction, Genetic | 4 | 2009 | 136 | 0.200 |
Why?
| | Antioxidants | 2 | 2020 | 595 | 0.200 |
Why?
| | Tongue | 2 | 2001 | 82 | 0.200 |
Why?
| | Oncogenes | 5 | 1994 | 118 | 0.190 |
Why?
| | Cilia | 2 | 2017 | 172 | 0.190 |
Why?
| | Wnt Proteins | 3 | 2010 | 136 | 0.190 |
Why?
| | Cytoskeleton | 8 | 1994 | 194 | 0.190 |
Why?
| | Epithelial Cells | 14 | 2006 | 1110 | 0.190 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 987 | 0.190 |
Why?
| | Alopecia | 4 | 2005 | 32 | 0.190 |
Why?
| | Cell Membrane | 7 | 2015 | 724 | 0.190 |
Why?
| | Hindlimb | 2 | 1999 | 134 | 0.190 |
Why?
| | Micromanipulation | 1 | 2002 | 14 | 0.180 |
Why?
| | Human Growth Hormone | 1 | 2002 | 48 | 0.180 |
Why?
| | Chromosome Mapping | 5 | 2016 | 504 | 0.180 |
Why?
| | Chile | 1 | 2021 | 23 | 0.180 |
Why?
| | Colombia | 1 | 2021 | 41 | 0.180 |
Why?
| | Hair Diseases | 1 | 2001 | 10 | 0.180 |
Why?
| | Nail Diseases | 1 | 2001 | 9 | 0.180 |
Why?
| | Permeability | 3 | 2016 | 166 | 0.180 |
Why?
| | Microscopy, Electron | 10 | 2002 | 441 | 0.180 |
Why?
| | Blister | 1 | 2001 | 40 | 0.180 |
Why?
| | I-kappa B Kinase | 4 | 2009 | 54 | 0.170 |
Why?
| | Molecular Imprinting | 1 | 2020 | 5 | 0.170 |
Why?
| | Mexico | 1 | 2021 | 232 | 0.170 |
Why?
| | Neoplasm Transplantation | 6 | 2016 | 250 | 0.170 |
Why?
| | Microscopy, Confocal | 1 | 2002 | 324 | 0.170 |
Why?
| | Carcinoma | 5 | 1995 | 230 | 0.170 |
Why?
| | RNA | 6 | 2018 | 930 | 0.160 |
Why?
| | Ceramides | 3 | 2016 | 118 | 0.160 |
Why?
| | Cloning, Molecular | 9 | 2002 | 533 | 0.160 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2008 | 274 | 0.160 |
Why?
| | Regenerative Medicine | 2 | 2019 | 52 | 0.160 |
Why?
| | Adult Stem Cells | 1 | 2020 | 40 | 0.160 |
Why?
| | Laser Capture Microdissection | 2 | 2017 | 32 | 0.160 |
Why?
| | Blotting, Western | 8 | 2007 | 1234 | 0.160 |
Why?
| | Cell Membrane Permeability | 1 | 2020 | 82 | 0.160 |
Why?
| | Fibroblasts | 6 | 2024 | 1020 | 0.160 |
Why?
| | Molecular Weight | 15 | 1990 | 329 | 0.160 |
Why?
| | Zebrafish Proteins | 1 | 2002 | 287 | 0.160 |
Why?
| | Bimatoprost | 1 | 2019 | 3 | 0.160 |
Why?
| | Genetic Linkage | 4 | 1999 | 288 | 0.160 |
Why?
| | Immunologic Surveillance | 1 | 2019 | 26 | 0.160 |
Why?
| | Papillomaviridae | 3 | 2016 | 133 | 0.160 |
Why?
| | Precancerous Conditions | 4 | 2004 | 166 | 0.150 |
Why?
| | Guided Tissue Regeneration | 1 | 2019 | 13 | 0.150 |
Why?
| | Antineoplastic Agents | 5 | 2016 | 2166 | 0.150 |
Why?
| | Crosses, Genetic | 4 | 2010 | 133 | 0.150 |
Why?
| | Arginine | 2 | 2007 | 260 | 0.150 |
Why?
| | Skin Aging | 2 | 1997 | 20 | 0.150 |
Why?
| | Deafness | 1 | 2000 | 77 | 0.150 |
Why?
| | Alopecia Areata | 1 | 2019 | 13 | 0.150 |
Why?
| | Threonine | 1 | 1999 | 47 | 0.150 |
Why?
| | Asparagine | 1 | 1999 | 32 | 0.150 |
Why?
| | Thymidine Kinase | 2 | 1998 | 15 | 0.150 |
Why?
| | Zinc Finger Protein GLI1 | 2 | 2017 | 26 | 0.150 |
Why?
| | Janus Kinase Inhibitors | 1 | 2019 | 27 | 0.150 |
Why?
| | Caspase 14 | 1 | 2018 | 1 | 0.150 |
Why?
| | Ovalbumin | 7 | 1981 | 196 | 0.150 |
Why?
| | Tumor Cells, Cultured | 7 | 2016 | 959 | 0.140 |
Why?
| | Simplexvirus | 2 | 1998 | 82 | 0.140 |
Why?
| | Microscopy, Immunoelectron | 4 | 2016 | 45 | 0.140 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2020 | 898 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-jun | 2 | 1999 | 57 | 0.140 |
Why?
| | Cytoprotection | 1 | 2018 | 57 | 0.140 |
Why?
| | Cellular Reprogramming Techniques | 1 | 2018 | 11 | 0.140 |
Why?
| | Autoimmunity | 1 | 2024 | 908 | 0.140 |
Why?
| | Transplantation, Heterologous | 3 | 2011 | 193 | 0.140 |
Why?
| | Potoroidae | 2 | 2007 | 3 | 0.140 |
Why?
| | Caspase 3 | 2 | 2010 | 250 | 0.140 |
Why?
| | Oncogene Proteins, Viral | 2 | 1994 | 22 | 0.130 |
Why?
| | Gene Silencing | 2 | 2016 | 196 | 0.130 |
Why?
| | Mammary Glands, Animal | 2 | 2006 | 131 | 0.130 |
Why?
| | Desmosomes | 2 | 2016 | 21 | 0.130 |
Why?
| | Receptors, Retinoic Acid | 1 | 1997 | 41 | 0.130 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 3 | 2013 | 236 | 0.130 |
Why?
| | Protein Multimerization | 1 | 2018 | 194 | 0.130 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 1997 | 57 | 0.130 |
Why?
| | Syndrome | 3 | 2009 | 378 | 0.130 |
Why?
| | Neovascularization, Pathologic | 1 | 1998 | 296 | 0.130 |
Why?
| | Mutagenesis, Site-Directed | 4 | 1999 | 377 | 0.130 |
Why?
| | Dermatitis, Atopic | 1 | 2020 | 331 | 0.130 |
Why?
| | Nucleic Acid Hybridization | 13 | 1991 | 189 | 0.130 |
Why?
| | Glucosylceramides | 1 | 2016 | 6 | 0.130 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2016 | 26 | 0.130 |
Why?
| | Kallikreins | 1 | 2016 | 27 | 0.130 |
Why?
| | Exons | 2 | 2016 | 353 | 0.130 |
Why?
| | Recombinant Fusion Proteins | 2 | 1996 | 672 | 0.120 |
Why?
| | Bone Morphogenetic Protein 4 | 2 | 2014 | 43 | 0.120 |
Why?
| | Gene Amplification | 2 | 2011 | 103 | 0.120 |
Why?
| | Side-Population Cells | 2 | 2013 | 8 | 0.120 |
Why?
| | SOXB1 Transcription Factors | 1 | 2016 | 63 | 0.120 |
Why?
| | Aldehyde Dehydrogenase | 2 | 2016 | 100 | 0.120 |
Why?
| | Microscopy, Fluorescence | 5 | 2007 | 417 | 0.120 |
Why?
| | Cell Movement | 5 | 2019 | 990 | 0.120 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2013 | 213 | 0.120 |
Why?
| | Genes, Regulator | 2 | 1993 | 36 | 0.120 |
Why?
| | Amino Acid Motifs | 1 | 2016 | 225 | 0.120 |
Why?
| | Bromodeoxyuridine | 3 | 2001 | 80 | 0.120 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2016 | 150 | 0.120 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1999 | 403 | 0.120 |
Why?
| | Cetuximab | 1 | 2015 | 105 | 0.120 |
Why?
| | Hematopoietic Stem Cells | 3 | 2015 | 411 | 0.110 |
Why?
| | Receptors, Progesterone | 3 | 2002 | 337 | 0.110 |
Why?
| | Hand Deformities, Congenital | 1 | 2014 | 10 | 0.110 |
Why?
| | Trachea | 4 | 1993 | 255 | 0.110 |
Why?
| | Chloracne | 1 | 2014 | 1 | 0.110 |
Why?
| | Keratin-2 | 3 | 2000 | 3 | 0.110 |
Why?
| | Cricetinae | 9 | 1994 | 301 | 0.110 |
Why?
| | RNA, Neoplasm | 6 | 1995 | 79 | 0.110 |
Why?
| | Dermis | 2 | 2010 | 34 | 0.110 |
Why?
| | Genes, Tumor Suppressor | 2 | 2004 | 82 | 0.110 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2014 | 67 | 0.100 |
Why?
| | Cellular Reprogramming | 1 | 2014 | 99 | 0.100 |
Why?
| | Transcriptional Activation | 4 | 2007 | 378 | 0.100 |
Why?
| | Hormones | 2 | 1994 | 140 | 0.100 |
Why?
| | Embryonic and Fetal Development | 3 | 2002 | 93 | 0.100 |
Why?
| | Recombination, Genetic | 2 | 2008 | 206 | 0.100 |
Why?
| | Smad4 Protein | 1 | 2013 | 35 | 0.100 |
Why?
| | Genetic Engineering | 2 | 2007 | 93 | 0.100 |
Why?
| | Nuclear Proteins | 3 | 2006 | 712 | 0.100 |
Why?
| | DNA Mutational Analysis | 3 | 2018 | 398 | 0.100 |
Why?
| | Vagina | 3 | 1994 | 194 | 0.100 |
Why?
| | Embryoid Bodies | 1 | 2013 | 8 | 0.100 |
Why?
| | Fatty Acid Transport Proteins | 1 | 2012 | 19 | 0.100 |
Why?
| | DNA Restriction Enzymes | 7 | 1998 | 51 | 0.100 |
Why?
| | Keratins, Hair-Specific | 1 | 2012 | 1 | 0.100 |
Why?
| | RNA Splice Sites | 1 | 2012 | 50 | 0.100 |
Why?
| | Polyploidy | 1 | 2012 | 13 | 0.100 |
Why?
| | Models, Animal | 4 | 2013 | 396 | 0.100 |
Why?
| | Polymorphism, Restriction Fragment Length | 3 | 2004 | 68 | 0.100 |
Why?
| | Macromolecular Substances | 7 | 1992 | 226 | 0.090 |
Why?
| | Cell Separation | 2 | 2007 | 317 | 0.090 |
Why?
| | Dermatology | 1 | 2014 | 122 | 0.090 |
Why?
| | Carrier Proteins | 2 | 2003 | 740 | 0.090 |
Why?
| | Quinone Reductases | 2 | 2002 | 17 | 0.090 |
Why?
| | RNA, Small Interfering | 3 | 2012 | 626 | 0.090 |
Why?
| | Binding Sites | 4 | 2006 | 1316 | 0.090 |
Why?
| | Fetal Diseases | 1 | 1994 | 181 | 0.090 |
Why?
| | Immunohistochemistry | 14 | 2007 | 1737 | 0.090 |
Why?
| | Embryo, Mammalian | 3 | 2010 | 236 | 0.090 |
Why?
| | Cancer Vaccines | 3 | 1998 | 167 | 0.090 |
Why?
| | MicroRNAs | 2 | 2015 | 689 | 0.090 |
Why?
| | Cerebellar Ataxia | 1 | 2011 | 13 | 0.090 |
Why?
| | Immunocompetence | 1 | 2011 | 44 | 0.090 |
Why?
| | Regulatory Sequences, Nucleic Acid | 3 | 1999 | 92 | 0.090 |
Why?
| | Cell Count | 2 | 1991 | 326 | 0.090 |
Why?
| | Epitopes | 3 | 1997 | 477 | 0.090 |
Why?
| | Sebaceous Glands | 1 | 2010 | 5 | 0.090 |
Why?
| | Keratolytic Agents | 1 | 2010 | 5 | 0.090 |
Why?
| | Integrins | 1 | 2011 | 96 | 0.090 |
Why?
| | Calcification, Physiologic | 1 | 2011 | 34 | 0.090 |
Why?
| | Introns | 4 | 2004 | 254 | 0.090 |
Why?
| | Carcinogenesis | 3 | 2021 | 215 | 0.090 |
Why?
| | Decidua | 1 | 2010 | 24 | 0.090 |
Why?
| | Ribosomal Proteins | 1 | 2011 | 92 | 0.090 |
Why?
| | Tumor Microenvironment | 1 | 2015 | 692 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-fos | 3 | 1999 | 191 | 0.080 |
Why?
| | Polymorphism, Genetic | 1 | 1993 | 625 | 0.080 |
Why?
| | Nevus | 1 | 2010 | 26 | 0.080 |
Why?
| | Adenocarcinoma, Sebaceous | 1 | 2010 | 2 | 0.080 |
Why?
| | Biomarkers, Tumor | 7 | 2009 | 1251 | 0.080 |
Why?
| | Sebaceous Gland Neoplasms | 1 | 2010 | 3 | 0.080 |
Why?
| | Genetic Techniques | 2 | 2005 | 67 | 0.080 |
Why?
| | Caspase 7 | 1 | 2010 | 22 | 0.080 |
Why?
| | Aneuploidy | 2 | 2007 | 89 | 0.080 |
Why?
| | Genotype | 4 | 2015 | 1859 | 0.080 |
Why?
| | In Situ Nick-End Labeling | 2 | 2007 | 126 | 0.080 |
Why?
| | Osteoblasts | 1 | 2011 | 134 | 0.080 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2012 | 830 | 0.080 |
Why?
| | Arachidonate 12-Lipoxygenase | 1 | 2009 | 18 | 0.080 |
Why?
| | Organ Specificity | 4 | 2007 | 312 | 0.080 |
Why?
| | Liver Regeneration | 1 | 2010 | 45 | 0.080 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 1990 | 68 | 0.080 |
Why?
| | Neoplasms | 2 | 2006 | 2741 | 0.080 |
Why?
| | Teratoma | 1 | 2010 | 118 | 0.080 |
Why?
| | Disease Susceptibility | 5 | 2006 | 352 | 0.080 |
Why?
| | Oviducts | 9 | 1982 | 15 | 0.080 |
Why?
| | Uterus | 1 | 2010 | 219 | 0.080 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2015 | 1073 | 0.080 |
Why?
| | Gene Expression Profiling | 4 | 2015 | 1764 | 0.080 |
Why?
| | Collagen | 2 | 1988 | 459 | 0.080 |
Why?
| | Mitochondria | 1 | 2015 | 967 | 0.080 |
Why?
| | Non-Fibrillar Collagens | 1 | 1988 | 2 | 0.080 |
Why?
| | Selection, Genetic | 1 | 2011 | 264 | 0.070 |
Why?
| | Down-Regulation | 4 | 2009 | 641 | 0.070 |
Why?
| | Osteogenesis | 1 | 2011 | 199 | 0.070 |
Why?
| | Pemphigoid, Bullous | 1 | 1988 | 8 | 0.070 |
Why?
| | Reactive Oxygen Species | 1 | 2012 | 630 | 0.070 |
Why?
| | Muscle, Smooth | 1 | 1990 | 154 | 0.070 |
Why?
| | Receptor, Notch1 | 2 | 2006 | 65 | 0.070 |
Why?
| | Gene Knockdown Techniques | 1 | 2009 | 330 | 0.070 |
Why?
| | Spindle Apparatus | 1 | 2009 | 103 | 0.070 |
Why?
| | beta-Galactosidase | 2 | 1999 | 78 | 0.070 |
Why?
| | Stress, Physiological | 1 | 2012 | 454 | 0.070 |
Why?
| | Foot | 1 | 2009 | 100 | 0.070 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2005 | 122 | 0.070 |
Why?
| | Hand | 1 | 2009 | 163 | 0.070 |
Why?
| | Genes, Lethal | 2 | 2008 | 30 | 0.070 |
Why?
| | Olfactory Mucosa | 1 | 2008 | 39 | 0.070 |
Why?
| | Integrin beta1 | 2 | 2013 | 25 | 0.070 |
Why?
| | Hoof and Claw | 1 | 2007 | 9 | 0.070 |
Why?
| | Cell Death | 1 | 2009 | 386 | 0.070 |
Why?
| | Bone Marrow | 2 | 2015 | 302 | 0.070 |
Why?
| | Protein Structure, Tertiary | 2 | 2007 | 859 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2010 | 464 | 0.070 |
Why?
| | Langerhans Cells | 2 | 1997 | 12 | 0.070 |
Why?
| | Protein Conformation | 6 | 1992 | 941 | 0.070 |
Why?
| | Cytoplasmic Granules | 4 | 2002 | 93 | 0.070 |
Why?
| | Growth Substances | 2 | 1999 | 148 | 0.070 |
Why?
| | Caspase 9 | 1 | 2007 | 57 | 0.070 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1998 | 159 | 0.070 |
Why?
| | Adult | 10 | 2020 | 39177 | 0.070 |
Why?
| | Cell Line, Tumor | 5 | 2015 | 3469 | 0.060 |
Why?
| | Species Specificity | 3 | 2000 | 583 | 0.060 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 1999 | 36 | 0.060 |
Why?
| | Neoplasm Proteins | 2 | 2006 | 432 | 0.060 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2006 | 18 | 0.060 |
Why?
| | Coculture Techniques | 2 | 2024 | 245 | 0.060 |
Why?
| | Cell Adhesion | 3 | 2015 | 468 | 0.060 |
Why?
| | Interleukin-1alpha | 2 | 2020 | 57 | 0.060 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2007 | 69 | 0.060 |
Why?
| | Ganciclovir | 2 | 1998 | 53 | 0.060 |
Why?
| | Twist-Related Protein 1 | 1 | 2006 | 9 | 0.060 |
Why?
| | Biological Assay | 1 | 2007 | 131 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1787 | 0.060 |
Why?
| | Mice, SCID | 3 | 2013 | 367 | 0.060 |
Why?
| | Glycine | 1 | 2007 | 182 | 0.060 |
Why?
| | Blotting, Northern | 6 | 1992 | 198 | 0.060 |
Why?
| | Lymphatic Metastasis | 1 | 2007 | 326 | 0.060 |
Why?
| | Phorbols | 1 | 1985 | 10 | 0.060 |
Why?
| | Darier Disease | 1 | 2005 | 2 | 0.060 |
Why?
| | Autoantigens | 1 | 1988 | 422 | 0.060 |
Why?
| | Antibodies | 2 | 1985 | 409 | 0.060 |
Why?
| | Stomach | 2 | 2006 | 110 | 0.060 |
Why?
| | Models, Genetic | 3 | 2008 | 591 | 0.060 |
Why?
| | Nucleic Acid Precursors | 3 | 1980 | 24 | 0.060 |
Why?
| | Protein Structure, Secondary | 2 | 1999 | 368 | 0.060 |
Why?
| | Enzyme Activation | 1 | 2007 | 811 | 0.060 |
Why?
| | Recombinant Proteins | 2 | 1999 | 1357 | 0.060 |
Why?
| | Flow Cytometry | 2 | 2007 | 1197 | 0.060 |
Why?
| | Cyclins | 2 | 1996 | 92 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2012 | 1330 | 0.060 |
Why?
| | Skin Abnormalities | 2 | 2002 | 12 | 0.060 |
Why?
| | Cell Adhesion Molecules | 1 | 2006 | 179 | 0.060 |
Why?
| | Cell Cycle Proteins | 2 | 2006 | 624 | 0.060 |
Why?
| | Retinal Dehydrogenase | 2 | 2016 | 29 | 0.060 |
Why?
| | Embryonic Development | 1 | 2005 | 118 | 0.060 |
Why?
| | Nerve Tissue Proteins | 1 | 1988 | 601 | 0.060 |
Why?
| | Melanins | 1 | 2024 | 16 | 0.060 |
Why?
| | RNA Interference | 3 | 2013 | 469 | 0.060 |
Why?
| | Cyclopropanes | 1 | 2024 | 71 | 0.050 |
Why?
| | Calcineurin | 1 | 2005 | 107 | 0.050 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 4 | 1990 | 336 | 0.050 |
Why?
| | Homeodomain Proteins | 2 | 2006 | 511 | 0.050 |
Why?
| | Boron Compounds | 1 | 2024 | 28 | 0.050 |
Why?
| | Sequence Analysis, RNA | 2 | 2017 | 450 | 0.050 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2024 | 9 | 0.050 |
Why?
| | Transglutaminases | 3 | 1995 | 156 | 0.050 |
Why?
| | Blotting, Southern | 3 | 2001 | 75 | 0.050 |
Why?
| | Aminopyridines | 1 | 2024 | 104 | 0.050 |
Why?
| | United States | 1 | 2021 | 15220 | 0.050 |
Why?
| | In Vitro Techniques | 4 | 2013 | 1093 | 0.050 |
Why?
| | Benzamides | 1 | 2024 | 216 | 0.050 |
Why?
| | Pregnancy | 5 | 2010 | 7070 | 0.050 |
Why?
| | Gene Editing | 1 | 2024 | 86 | 0.050 |
Why?
| | Receptors, Cell Surface | 2 | 2005 | 397 | 0.050 |
Why?
| | Tissue Distribution | 2 | 2002 | 330 | 0.050 |
Why?
| | Body Weight | 2 | 2011 | 996 | 0.050 |
Why?
| | Transplantation, Autologous | 1 | 2024 | 280 | 0.050 |
Why?
| | Time Factors | 5 | 2004 | 6956 | 0.050 |
Why?
| | Vimentin | 4 | 1994 | 52 | 0.050 |
Why?
| | Molecular Structure | 2 | 1994 | 503 | 0.050 |
Why?
| | CRISPR-Cas Systems | 1 | 2024 | 150 | 0.050 |
Why?
| | Vitamin K 3 | 1 | 2002 | 3 | 0.050 |
Why?
| | Biomarkers | 5 | 2004 | 4174 | 0.050 |
Why?
| | Genetic Variation | 2 | 1998 | 1000 | 0.050 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2024 | 238 | 0.050 |
Why?
| | S100 Proteins | 2 | 2000 | 37 | 0.050 |
Why?
| | Dacarbazine | 2 | 2012 | 98 | 0.050 |
Why?
| | Keratin-15 | 1 | 2002 | 17 | 0.050 |
Why?
| | Bioreactors | 1 | 2002 | 48 | 0.050 |
Why?
| | Keratin-5 | 1 | 2002 | 49 | 0.050 |
Why?
| | Immunoenzyme Techniques | 4 | 1993 | 209 | 0.040 |
Why?
| | Isomerism | 1 | 2001 | 56 | 0.040 |
Why?
| | Mesocricetus | 5 | 1993 | 45 | 0.040 |
Why?
| | 3T3 Cells | 3 | 2013 | 164 | 0.040 |
Why?
| | Vitamin A Deficiency | 3 | 1993 | 27 | 0.040 |
Why?
| | Starvation | 1 | 2001 | 23 | 0.040 |
Why?
| | Luteolytic Agents | 1 | 2001 | 1 | 0.040 |
Why?
| | Mouth Diseases | 1 | 2001 | 44 | 0.040 |
Why?
| | Bone and Bones | 1 | 2004 | 317 | 0.040 |
Why?
| | Lasers | 1 | 2002 | 130 | 0.040 |
Why?
| | Administration, Topical | 3 | 1997 | 150 | 0.040 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2004 | 431 | 0.040 |
Why?
| | Autoantibodies | 1 | 1988 | 1470 | 0.040 |
Why?
| | Benzo(a)pyrene | 1 | 2000 | 8 | 0.040 |
Why?
| | Response Elements | 2 | 2012 | 90 | 0.040 |
Why?
| | Nuclear Localization Signals | 1 | 2000 | 18 | 0.040 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2000 | 34 | 0.040 |
Why?
| | Frameshift Mutation | 1 | 2000 | 32 | 0.040 |
Why?
| | Cell Compartmentation | 1 | 2000 | 53 | 0.040 |
Why?
| | Dermatitis, Exfoliative | 1 | 2020 | 3 | 0.040 |
Why?
| | Netherton Syndrome | 1 | 2020 | 3 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2001 | 391 | 0.040 |
Why?
| | Cell Survival | 3 | 2013 | 1129 | 0.040 |
Why?
| | Adaptation, Biological | 1 | 2000 | 54 | 0.040 |
Why?
| | Chickens | 9 | 1995 | 189 | 0.040 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2020 | 54 | 0.040 |
Why?
| | Immunoblotting | 4 | 2003 | 310 | 0.040 |
Why?
| | Rats | 5 | 1994 | 5629 | 0.040 |
Why?
| | Zebrafish | 1 | 2004 | 500 | 0.040 |
Why?
| | rho GTP-Binding Proteins | 1 | 2020 | 60 | 0.040 |
Why?
| | Repressor Proteins | 2 | 2013 | 425 | 0.040 |
Why?
| | Cell Nucleus | 7 | 2004 | 609 | 0.040 |
Why?
| | Estrenes | 1 | 1999 | 16 | 0.040 |
Why?
| | DNA, Complementary | 2 | 2003 | 274 | 0.040 |
Why?
| | DNA, Neoplasm | 3 | 1995 | 158 | 0.040 |
Why?
| | Kidney | 1 | 2007 | 1482 | 0.040 |
Why?
| | Restriction Mapping | 1 | 1999 | 76 | 0.040 |
Why?
| | Genomic Library | 1 | 1999 | 17 | 0.040 |
Why?
| | Genetic Carrier Screening | 1 | 1999 | 30 | 0.040 |
Why?
| | Phototherapy | 1 | 2019 | 46 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2019 | 54 | 0.040 |
Why?
| | Forelimb | 1 | 1999 | 39 | 0.040 |
Why?
| | DNA Damage | 2 | 2012 | 427 | 0.040 |
Why?
| | RNA, Heterogeneous Nuclear | 1 | 1978 | 6 | 0.040 |
Why?
| | Sequence Analysis | 1 | 1998 | 36 | 0.040 |
Why?
| | Protein Transport | 1 | 2000 | 448 | 0.040 |
Why?
| | Reference Values | 3 | 2002 | 805 | 0.040 |
Why?
| | Thrombospondin 1 | 1 | 1998 | 28 | 0.040 |
Why?
| | Dimerization | 1 | 1999 | 196 | 0.040 |
Why?
| | Fungal Proteins | 1 | 1999 | 137 | 0.040 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 1998 | 80 | 0.040 |
Why?
| | Endothelial Growth Factors | 1 | 1998 | 65 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2011 | 2250 | 0.040 |
Why?
| | Peptides | 1 | 1984 | 978 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2011 | 761 | 0.040 |
Why?
| | Lymphokines | 1 | 1998 | 133 | 0.040 |
Why?
| | Body Patterning | 1 | 1999 | 136 | 0.040 |
Why?
| | Mutagenesis, Insertional | 1 | 1998 | 65 | 0.040 |
Why?
| | Genes, bcl-2 | 1 | 1998 | 22 | 0.040 |
Why?
| | Neovascularization, Physiologic | 1 | 1999 | 182 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2002 | 1018 | 0.030 |
Why?
| | Age of Onset | 1 | 1999 | 532 | 0.030 |
Why?
| | Psoriasis | 2 | 1996 | 110 | 0.030 |
Why?
| | Gamma Rays | 1 | 1998 | 57 | 0.030 |
Why?
| | Retinoic Acid Receptor alpha | 1 | 1997 | 16 | 0.030 |
Why?
| | Antigens, Neoplasm | 2 | 1997 | 321 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2006 | 2363 | 0.030 |
Why?
| | Oxazines | 1 | 1997 | 32 | 0.030 |
Why?
| | Retinoid X Receptors | 1 | 1997 | 38 | 0.030 |
Why?
| | Epidermal Growth Factor | 3 | 1993 | 176 | 0.030 |
Why?
| | Thymus Gland | 1 | 1998 | 319 | 0.030 |
Why?
| | Protein Binding | 3 | 2009 | 2239 | 0.030 |
Why?
| | Mitotic Index | 1 | 1997 | 24 | 0.030 |
Why?
| | Metaplasia | 3 | 1993 | 58 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2000 | 835 | 0.030 |
Why?
| | Receptors, Calcitriol | 1 | 1997 | 55 | 0.030 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 1997 | 73 | 0.030 |
Why?
| | Clinical Trials, Phase I as Topic | 1 | 1997 | 51 | 0.030 |
Why?
| | Luciferases | 2 | 2009 | 150 | 0.030 |
Why?
| | Hybrid Cells | 2 | 1994 | 48 | 0.030 |
Why?
| | Carcinogenicity Tests | 2 | 1994 | 10 | 0.030 |
Why?
| | Interleukin-2 | 1 | 1998 | 453 | 0.030 |
Why?
| | Hypertrophy | 1 | 1997 | 136 | 0.030 |
Why?
| | Organ Culture Techniques | 4 | 1990 | 157 | 0.030 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 1987 | 114 | 0.030 |
Why?
| | Body Temperature | 1 | 1997 | 224 | 0.030 |
Why?
| | Hyaluronan Receptors | 1 | 2016 | 103 | 0.030 |
Why?
| | Extremities | 1 | 1997 | 140 | 0.030 |
Why?
| | Rats, Inbred F344 | 2 | 1993 | 269 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 1998 | 550 | 0.030 |
Why?
| | Rabbits | 2 | 1996 | 754 | 0.030 |
Why?
| | Kinetics | 5 | 1994 | 1652 | 0.030 |
Why?
| | Spheroids, Cellular | 1 | 2016 | 77 | 0.030 |
Why?
| | Phospholipids | 1 | 1997 | 221 | 0.030 |
Why?
| | Biopsy | 2 | 1997 | 1081 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 1998 | 674 | 0.030 |
Why?
| | Maximum Tolerated Dose | 1 | 2015 | 206 | 0.030 |
Why?
| | PAX3 Transcription Factor | 1 | 2015 | 17 | 0.030 |
Why?
| | Fluorescent Dyes | 1 | 1997 | 324 | 0.030 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1995 | 156 | 0.030 |
Why?
| | Paired Box Transcription Factors | 1 | 2015 | 46 | 0.030 |
Why?
| | Inhibins | 1 | 1995 | 42 | 0.030 |
Why?
| | Interleukins | 1 | 1997 | 248 | 0.030 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2015 | 70 | 0.030 |
Why?
| | Random Allocation | 1 | 2016 | 367 | 0.030 |
Why?
| | Benzoates | 1 | 1995 | 46 | 0.030 |
Why?
| | Cantharidin | 1 | 1994 | 1 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 346 | 0.030 |
Why?
| | Ainhum | 1 | 2014 | 1 | 0.030 |
Why?
| | Tetrahydronaphthalenes | 1 | 1995 | 30 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2015 | 67 | 0.030 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 1997 | 208 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 1998 | 1243 | 0.030 |
Why?
| | DNA Probes, HPV | 1 | 1994 | 1 | 0.030 |
Why?
| | Evaluation Studies as Topic | 1 | 1994 | 175 | 0.030 |
Why?
| | Sequence Alignment | 1 | 1995 | 363 | 0.030 |
Why?
| | Actin Cytoskeleton | 1 | 1995 | 103 | 0.030 |
Why?
| | Staining and Labeling | 2 | 2010 | 154 | 0.030 |
Why?
| | Ornithine Decarboxylase | 1 | 1994 | 13 | 0.030 |
Why?
| | Epigen | 1 | 2014 | 1 | 0.030 |
Why?
| | Secretory Leukocyte Peptidase Inhibitor | 1 | 2014 | 6 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 852 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2015 | 715 | 0.030 |
Why?
| | Simian virus 40 | 1 | 1993 | 25 | 0.030 |
Why?
| | TATA Box | 1 | 1993 | 22 | 0.030 |
Why?
| | Collagen Type IV | 1 | 2014 | 28 | 0.030 |
Why?
| | Chorionic Villi | 1 | 1994 | 25 | 0.030 |
Why?
| | Lung Neoplasms | 1 | 2007 | 2560 | 0.030 |
Why?
| | Open Reading Frames | 1 | 1994 | 132 | 0.030 |
Why?
| | Laminin | 1 | 1994 | 72 | 0.030 |
Why?
| | alpha Catenin | 1 | 2013 | 11 | 0.030 |
Why?
| | Middle Aged | 5 | 2020 | 34434 | 0.030 |
Why?
| | Butylhydroxybutylnitrosamine | 1 | 1993 | 6 | 0.030 |
Why?
| | Multigene Family | 1 | 1994 | 202 | 0.030 |
Why?
| | Clone Cells | 2 | 2010 | 266 | 0.030 |
Why?
| | Cholecalciferol | 1 | 1994 | 61 | 0.030 |
Why?
| | Cell Dedifferentiation | 1 | 2013 | 31 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2014 | 238 | 0.030 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2013 | 49 | 0.030 |
Why?
| | Mice, Inbred CBA | 1 | 2013 | 54 | 0.030 |
Why?
| | Ovariectomy | 1 | 1994 | 158 | 0.030 |
Why?
| | Antigens, CD | 1 | 2016 | 539 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2020 | 11120 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2016 | 423 | 0.030 |
Why?
| | Sulfur Radioisotopes | 2 | 1990 | 15 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2009 | 6275 | 0.020 |
Why?
| | DNA Probes | 2 | 1992 | 59 | 0.020 |
Why?
| | Collagen Type I | 1 | 2014 | 139 | 0.020 |
Why?
| | ErbB Receptors | 1 | 2016 | 610 | 0.020 |
Why?
| | Protein Biosynthesis | 6 | 1991 | 444 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2013 | 183 | 0.020 |
Why?
| | Glycoproteins | 1 | 1995 | 356 | 0.020 |
Why?
| | Chromosomes, Mammalian | 1 | 2012 | 28 | 0.020 |
Why?
| | Diseases in Twins | 1 | 1994 | 159 | 0.020 |
Why?
| | Lentivirus | 1 | 2013 | 59 | 0.020 |
Why?
| | Forecasting | 1 | 1994 | 384 | 0.020 |
Why?
| | Aldehyde Oxidoreductases | 1 | 2012 | 27 | 0.020 |
Why?
| | Breast | 1 | 1993 | 158 | 0.020 |
Why?
| | Child | 3 | 2020 | 22308 | 0.020 |
Why?
| | Egg Proteins | 3 | 1982 | 21 | 0.020 |
Why?
| | Serine | 1 | 1993 | 148 | 0.020 |
Why?
| | Viruses | 1 | 1994 | 163 | 0.020 |
Why?
| | Bacteriophage lambda | 1 | 1993 | 89 | 0.020 |
Why?
| | Limb Buds | 2 | 2004 | 23 | 0.020 |
Why?
| | Coloring Agents | 1 | 2012 | 96 | 0.020 |
Why?
| | Cysteine | 1 | 1993 | 205 | 0.020 |
Why?
| | Isoenzymes | 1 | 2012 | 302 | 0.020 |
Why?
| | Tritium | 3 | 1994 | 72 | 0.020 |
Why?
| | Myoepithelioma | 1 | 1991 | 3 | 0.020 |
Why?
| | Mutagenicity Tests | 1 | 2011 | 13 | 0.020 |
Why?
| | Gene Knock-In Techniques | 1 | 2011 | 57 | 0.020 |
Why?
| | Avian Leukosis Virus | 1 | 2011 | 6 | 0.020 |
Why?
| | Age Factors | 2 | 1996 | 3292 | 0.020 |
Why?
| | Integrin-Binding Sialoprotein | 1 | 2011 | 5 | 0.020 |
Why?
| | Rodent Diseases | 1 | 1991 | 28 | 0.020 |
Why?
| | Ovomucin | 2 | 1982 | 10 | 0.020 |
Why?
| | Moloney murine leukemia virus | 1 | 1991 | 13 | 0.020 |
Why?
| | Biological Evolution | 2 | 1985 | 490 | 0.020 |
Why?
| | Haploinsufficiency | 1 | 2011 | 56 | 0.020 |
Why?
| | Hyperpigmentation | 1 | 2011 | 27 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2012 | 273 | 0.020 |
Why?
| | Osteocalcin | 1 | 2011 | 38 | 0.020 |
Why?
| | Proteome | 1 | 2015 | 483 | 0.020 |
Why?
| | Paclitaxel | 1 | 2012 | 237 | 0.020 |
Why?
| | Progesterone | 2 | 2010 | 260 | 0.020 |
Why?
| | Embryo Implantation | 1 | 2010 | 30 | 0.020 |
Why?
| | Wnt4 Protein | 1 | 2010 | 20 | 0.020 |
Why?
| | Growth Disorders | 1 | 2011 | 87 | 0.020 |
Why?
| | Immunosorbent Techniques | 2 | 1987 | 19 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1973 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2012 | 600 | 0.020 |
Why?
| | Infant | 2 | 2009 | 9818 | 0.020 |
Why?
| | Swine | 1 | 1993 | 806 | 0.020 |
Why?
| | Cytokines | 2 | 2015 | 2098 | 0.020 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 1997 | 918 | 0.020 |
Why?
| | Pigmentation | 1 | 2010 | 53 | 0.020 |
Why?
| | Mitosis | 1 | 2011 | 196 | 0.020 |
Why?
| | Urinary Bladder Neoplasms | 1 | 1993 | 256 | 0.020 |
Why?
| | Estrogens | 4 | 1982 | 367 | 0.020 |
Why?
| | Phospholipases A2 | 1 | 2010 | 83 | 0.020 |
Why?
| | DNA Repair | 1 | 2012 | 234 | 0.020 |
Why?
| | Mouth Mucosa | 1 | 1990 | 90 | 0.020 |
Why?
| | Animals, Wild | 1 | 1990 | 62 | 0.020 |
Why?
| | Adenoma, Pleomorphic | 1 | 1990 | 10 | 0.020 |
Why?
| | Parotid Neoplasms | 1 | 1990 | 15 | 0.020 |
Why?
| | Liver | 2 | 2002 | 1819 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1820 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 1994 | 1498 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 1003 | 0.020 |
Why?
| | Smad3 Protein | 1 | 2009 | 44 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2009 | 90 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 1998 | 2002 | 0.020 |
Why?
| | Child, Preschool | 2 | 2009 | 11457 | 0.020 |
Why?
| | Arachidonic Acid | 1 | 2010 | 126 | 0.020 |
Why?
| | Amino Acids | 4 | 2002 | 497 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 1990 | 270 | 0.020 |
Why?
| | Anemia | 1 | 2011 | 177 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 1999 | 5200 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2009 | 136 | 0.020 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2009 | 89 | 0.020 |
Why?
| | Imidazoles | 1 | 2010 | 244 | 0.020 |
Why?
| | Dinoprostone | 1 | 2010 | 191 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2010 | 175 | 0.020 |
Why?
| | Diethylstilbestrol | 2 | 1979 | 9 | 0.020 |
Why?
| | Dystonin | 1 | 1988 | 1 | 0.020 |
Why?
| | Ameloblastoma | 1 | 1988 | 5 | 0.020 |
Why?
| | Cell Communication | 1 | 2010 | 318 | 0.020 |
Why?
| | Methionine | 1 | 1989 | 159 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3588 | 0.020 |
Why?
| | Lactation | 1 | 1990 | 192 | 0.020 |
Why?
| | Tissue Scaffolds | 1 | 2011 | 213 | 0.020 |
Why?
| | Cellular Senescence | 1 | 2010 | 205 | 0.020 |
Why?
| | Vitamin A | 2 | 1986 | 57 | 0.020 |
Why?
| | gamma-Glutamyltransferase | 1 | 1988 | 42 | 0.020 |
Why?
| | Piperazines | 1 | 2010 | 354 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 509 | 0.020 |
Why?
| | Isoelectric Point | 1 | 1987 | 23 | 0.020 |
Why?
| | Antigens, Differentiation | 1 | 1988 | 82 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 855 | 0.020 |
Why?
| | Survival Analysis | 1 | 2010 | 1319 | 0.020 |
Why?
| | Protease Inhibitors | 1 | 1988 | 105 | 0.020 |
Why?
| | Interferon-gamma | 1 | 1990 | 792 | 0.020 |
Why?
| | Antigens, Ly | 1 | 1987 | 43 | 0.020 |
Why?
| | Organoids | 1 | 1988 | 129 | 0.020 |
Why?
| | Harvey murine sarcoma virus | 1 | 1986 | 1 | 0.020 |
Why?
| | Dimethyl Sulfoxide | 1 | 1987 | 41 | 0.020 |
Why?
| | Occludin | 1 | 2006 | 12 | 0.020 |
Why?
| | LIM Domain Proteins | 1 | 2006 | 20 | 0.020 |
Why?
| | Claudin-1 | 1 | 2006 | 15 | 0.020 |
Why?
| | Olfactory Bulb | 1 | 2008 | 98 | 0.020 |
Why?
| | Minichromosome Maintenance Complex Component 7 | 1 | 2006 | 4 | 0.020 |
Why?
| | Immunoassay | 1 | 1987 | 113 | 0.020 |
Why?
| | Receptors, Steroid | 1 | 2006 | 46 | 0.020 |
Why?
| | Interleukin-6 | 1 | 1990 | 792 | 0.020 |
Why?
| | Chemistry | 1 | 1985 | 44 | 0.010 |
Why?
| | Chemical Phenomena | 1 | 1985 | 82 | 0.010 |
Why?
| | Fluocinolone Acetonide | 1 | 1985 | 15 | 0.010 |
Why?
| | X-Ray Diffraction | 1 | 1985 | 104 | 0.010 |
Why?
| | Calcium-Binding Proteins | 1 | 1986 | 216 | 0.010 |
Why?
| | Microscopy, Electron, Scanning | 1 | 1985 | 203 | 0.010 |
Why?
| | HeLa Cells | 1 | 2007 | 640 | 0.010 |
Why?
| | Phosphorylation | 1 | 2009 | 1768 | 0.010 |
Why?
| | Erythroid-Specific DNA-Binding Factors | 1 | 2004 | 15 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2012 | 2132 | 0.010 |
Why?
| | Cattle | 2 | 1988 | 998 | 0.010 |
Why?
| | Calcineurin Inhibitors | 1 | 2005 | 70 | 0.010 |
Why?
| | YY1 Transcription Factor | 1 | 2004 | 22 | 0.010 |
Why?
| | Protein Processing, Post-Translational | 1 | 1987 | 464 | 0.010 |
Why?
| | NFATC Transcription Factors | 1 | 2005 | 94 | 0.010 |
Why?
| | Base Composition | 1 | 1984 | 79 | 0.010 |
Why?
| | Hormone Antagonists | 1 | 2004 | 34 | 0.010 |
Why?
| | Thymidine | 2 | 1994 | 60 | 0.010 |
Why?
| | Antigen-Antibody Complex | 1 | 1984 | 87 | 0.010 |
Why?
| | Aged | 3 | 2020 | 24574 | 0.010 |
Why?
| | Fibroblast Growth Factor 8 | 1 | 2004 | 27 | 0.010 |
Why?
| | Interleukin-1 | 1 | 1988 | 968 | 0.010 |
Why?
| | Receptors, Fibroblast Growth Factor | 1 | 2004 | 68 | 0.010 |
Why?
| | src-Family Kinases | 1 | 2004 | 93 | 0.010 |
Why?
| | Stomach Diseases | 1 | 2003 | 19 | 0.010 |
Why?
| | Weaning | 1 | 2003 | 46 | 0.010 |
Why?
| | Craniofacial Abnormalities | 1 | 2004 | 75 | 0.010 |
Why?
| | Antibodies, Monoclonal | 2 | 1990 | 1448 | 0.010 |
Why?
| | Esophageal Diseases | 1 | 2003 | 28 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 13673 | 0.010 |
Why?
| | Terminology as Topic | 1 | 1985 | 244 | 0.010 |
Why?
| | Mice, Hairless | 2 | 1994 | 59 | 0.010 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2003 | 67 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 1987 | 555 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2008 | 1052 | 0.010 |
Why?
| | Adolescent | 2 | 2020 | 22007 | 0.010 |
Why?
| | Fibroblast Growth Factors | 1 | 2004 | 180 | 0.010 |
Why?
| | Aging | 1 | 1993 | 1892 | 0.010 |
Why?
| | Cheek | 2 | 1993 | 17 | 0.010 |
Why?
| | Fertility | 1 | 2002 | 165 | 0.010 |
Why?
| | RNA, Small Nuclear | 1 | 1981 | 37 | 0.010 |
Why?
| | Mice, Inbred A | 1 | 2000 | 51 | 0.010 |
Why?
| | Biotransformation | 1 | 2000 | 62 | 0.010 |
Why?
| | Peptide Fragments | 1 | 1984 | 698 | 0.010 |
Why?
| | Risk Factors | 1 | 1994 | 10438 | 0.010 |
Why?
| | Sequence Homology | 1 | 1999 | 43 | 0.010 |
Why?
| | Limb Deformities, Congenital | 1 | 1999 | 21 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2003 | 2064 | 0.010 |
Why?
| | Neurons | 1 | 2008 | 1619 | 0.010 |
Why?
| | Phosphorus Radioisotopes | 1 | 1978 | 27 | 0.010 |
Why?
| | Globins | 1 | 1978 | 21 | 0.010 |
Why?
| | Reticulocytes | 1 | 1978 | 17 | 0.010 |
Why?
| | Cholera Toxin | 2 | 1988 | 31 | 0.010 |
Why?
| | Polyribosomes | 1 | 1978 | 24 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 1998 | 101 | 0.010 |
Why?
| | Antibody Specificity | 2 | 1989 | 187 | 0.010 |
Why?
| | DNA Fragmentation | 1 | 1998 | 41 | 0.010 |
Why?
| | Drug Stability | 1 | 1978 | 166 | 0.010 |
Why?
| | Isotope Labeling | 1 | 1978 | 81 | 0.010 |
Why?
| | RNA Polymerase II | 1 | 1981 | 339 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 335 | 0.010 |
Why?
| | Immunologic Techniques | 2 | 1986 | 39 | 0.010 |
Why?
| | Desmogleins | 1 | 1996 | 3 | 0.010 |
Why?
| | T-Lymphocyte Subsets | 1 | 1998 | 415 | 0.010 |
Why?
| | Desmoplakins | 1 | 1996 | 20 | 0.010 |
Why?
| | Receptors, Estrogen | 1 | 1979 | 412 | 0.010 |
Why?
| | Follistatin | 1 | 1995 | 12 | 0.010 |
Why?
| | Vibrissae | 1 | 1995 | 10 | 0.010 |
Why?
| | Activins | 1 | 1995 | 29 | 0.010 |
Why?
| | Musculoskeletal Abnormalities | 1 | 1995 | 14 | 0.010 |
Why?
| | Xenopus | 1 | 1995 | 89 | 0.010 |
Why?
| | Palate | 1 | 1995 | 40 | 0.010 |
Why?
| | Musculoskeletal System | 1 | 1995 | 49 | 0.010 |
Why?
| | Estrus | 1 | 1994 | 11 | 0.010 |
Why?
| | Acetone | 1 | 1994 | 12 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 1998 | 720 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 1997 | 501 | 0.010 |
Why?
| | Lymph Nodes | 1 | 1997 | 502 | 0.010 |
Why?
| | Skull | 1 | 1995 | 151 | 0.010 |
Why?
| | Cell Fusion | 1 | 1993 | 50 | 0.010 |
Why?
| | Dendritic Cells | 1 | 1997 | 505 | 0.010 |
Why?
| | Protein Kinase C | 1 | 1994 | 252 | 0.010 |
Why?
| | Organelles | 1 | 1991 | 57 | 0.010 |
Why?
| | Cell Line, Transformed | 1 | 1991 | 145 | 0.010 |
Why?
| | Retroviridae | 1 | 1991 | 103 | 0.010 |
Why?
| | Peptide Mapping | 1 | 1990 | 65 | 0.010 |
Why?
| | Trypsin | 1 | 1990 | 76 | 0.010 |
Why?
| | von Willebrand Factor | 1 | 1990 | 84 | 0.000 |
Why?
| | DNA, Recombinant | 2 | 1979 | 48 | 0.000 |
Why?
| | RNA Probes | 1 | 1988 | 13 | 0.000 |
Why?
| | Autoradiography | 1 | 1988 | 69 | 0.000 |
Why?
| | HLA-DR Antigens | 1 | 1990 | 228 | 0.000 |
Why?
| | Histocytochemistry | 1 | 1988 | 80 | 0.000 |
Why?
| | Metaphase | 1 | 1988 | 32 | 0.000 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 1988 | 49 | 0.000 |
Why?
| | Microbial Collagenase | 1 | 1987 | 12 | 0.000 |
Why?
| | Cytoplasm | 1 | 1988 | 273 | 0.000 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 1988 | 112 | 0.000 |
Why?
| | Culture Techniques | 1 | 1987 | 74 | 0.000 |
Why?
| | Cross Reactions | 1 | 1988 | 133 | 0.000 |
Why?
| | Light | 1 | 1990 | 394 | 0.000 |
Why?
| | Leukemia, Radiation-Induced | 1 | 1987 | 4 | 0.000 |
Why?
| | Proto-Oncogene Proteins c-sis | 1 | 1987 | 39 | 0.000 |
Why?
| | Leukemia, Experimental | 1 | 1987 | 28 | 0.000 |
Why?
| | Cricetulus | 1 | 1987 | 111 | 0.000 |
Why?
| | Diterpenes | 1 | 1986 | 27 | 0.000 |
Why?
| | Genetic Markers | 1 | 1987 | 343 | 0.000 |
Why?
| | Inflammation | 1 | 1997 | 2890 | 0.000 |
Why?
| | Incidence | 1 | 1991 | 2794 | 0.000 |
Why?
| | Lipopolysaccharides | 1 | 1988 | 889 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1996 | 7856 | 0.000 |
Why?
| | Poly A | 1 | 1982 | 52 | 0.000 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 1979 | 63 | 0.000 |
Why?
| | Retrospective Studies | 1 | 1991 | 16273 | 0.000 |
Why?
|
|
Roop's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|